Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?

Shafiee et al. (2021) recognize that repeated use of anti-inflammatory agents, the current treatment for inflammatory bowel disease (IBD), can have adverse effects on the patient. The aim of this review was to outline the current literature regarding the anti-inflammatory diet’s effectiveness in IBD. Recently, diet-related strategies have been formulated to try to improve the clinical activity scores in IBD patients. A promising approach is the modification of microbiota living in the digestive tracts through dietary therapy, which has been reported to improve IBD outcomes. The anti-inflammatory diet has been recommended as it restricts the consumption of carbohydrates that contain modified fatty acids. This diet also contains probiotics and prebiotics that can promote balanced intestinal microbiota composition. However, the authors emphasize that there is not yet clear evidence that supports this type of diet for the maintenance of remission or for prevention of IBD relapse. [NPID: pain, inflammation, IBD, digestion]

Year: 2021

Reference: Shafiee, N. H., Manaf, Z. A., Mokhtar, N. M., & Raja Ali, R. A. (2021). Anti-inflammatory diet and inflammatory bowel disease: what clinicians and patients should know?. Intestinal research, 19(2), 171–185. https://doi.org/10.5217/ir.2020.00035